05-Nov-15 China has launched a three-year pilot scheme to loosen approvals for new drugs, the country's food and drug regulator said, as Beijing looks to help stimulate innovation in the country's pharmaceutical sector. The trial will allow research and development bodies to seek drug approvals, which are currently restricted to drug manufacturers. [image: ET Healthworld]

03-Nov-15 Chinese diabetes tech firm Sinocare has signed an agreement to acquire Nipro Diagnostics from Japan's Nipro Corp, for USD273 mn. Nipro Diagnostics is based in Florida and manufacturers products for people with diabetes, including a portfolio of blood glucose monitoring technologies. Sinocare CEO Shaobo Li said “Diabetes has become one of the biggest challenges to our public healthcare system and society." [image: Sinocare]

03-Nov-15 The Communist Party of China has vowed to build a "healthy China" with a better health system and balancing the population through the two-child policy. In a proposal for the 13th five-year plan (2016-2020), the CPC called for an efficient basic healthcare system in both urban and rural areas and modern management of hospitals. [image: Xinhua Finance Agency]

29-Oct-15 China's healthcare products exports have increased by 18% a year since 2008, reaching nearly USD13 bn in 2014. Medical device exporters - including Microport, Mindray, Kanghui, Wego and Andon - are not only targeting Western countries but emerging markets as well. Chinese brands are perceived as competitive on price and quality, but viewed less favorably on value and reliability. [image: Reuters]

29-Oct-15 The medical contract manufacturer BIT Group has established a second Chinese manufacturing operation in Shenzhen, China, as a joint venture with EDAN Instruments, a Shenzhen-based patient monitoring technology company. “The Chinese medical technology market is expected to grow at double digit rates in the coming years,” said Marius Balger, BIT CEO. [image: Invetech].